COVID-19 infection increases the risk of developing irritable bowel syndrome in the long term

by Vall d’Hebron

1 year ago
irritable bowel syndrome

Recently, an international study (GI-COVID19), led by the University Hospital of Bologna (Italy) and with the participation of Vall d'Hebron, has been completed, in which persistent gastrointestinal m...

Large-scale genetic study reveals new clues for the shared origins of irritable bowel syndrome and mental health disorders

by CIC bioGUNE

2 years ago
Ikerbasque, CIC bioGUNE, BRTA, irritable bowel syndrome, mental health disorders

The study, co-led by researchers from CIC bioGUNE, has analysed genetic data from over 50,000 patients. The research highlights the close relationship between brain and gut health and paves the way f...

Two new markers related to the epithelial permeability in the irritable bowel syndrome

by Vall d’Hebron

7 years ago
irritable bowel syndrome, microRNA 16, microRNA 125b, Claudin, Cingulin, epithelial permeability

The research shows how the microRNAs 16 and 125b modulate the molecules Claudin 2 and Cingulin in a different way in the intestine of patients than in the intestine of healthy controls. The function o...

Dr. Santos writes a review about the genetic and epigenetic factors in irritable bowel syndrome

by Vall d’Hebron

8 years ago
microRNAs, irritable bowel syndrome, epigenetic

The goal of the article was to review all the studies that have been conducted in the past 7 years in the field of the irritable bowel syndrome. This condition affects up to 20% of the western populat...

Patients with diarrhoea-predominant irritable bowel syndrome have less microbial diversity

by Vall d’Hebron

9 years ago
irritable bowel syndrome, diarrhoea

Is it estimated that 11% of the population suffers from irritable bowel syndrome. Only in Vall d’Hebron, the Physiology and Pathophysiology of the Digestive Tract Unit has more than a thousand patie...